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Introduction 
For decades, America’s healthcare system has kept price and 
quality information secret from the patients who need it. 
Healthcare experts all across the political spectrum have long 
agreed this has to change.1 
 
 – Alex Azar, Secretary of Health and Human Services 
 
It is no secret that the United States has significantly higher health 
care prices compared to the rest of the world.2 American patients and 
insurance companies pay higher prices for basic health visits, 
pharmaceutical drugs, medical tests, and common procedures.3 
Consumers often cannot find cost estimates for medical services before 
care delivery, and providers usually do not offer accurate price 
estimations.4 The increasing health care prices, in addition to 
undisclosed or imprecise cost estimates, make lowering health care costs 
a pressing but difficult national issue.5 The United States’ federal 
government and individual state governments are currently considering 
bills and passing laws to address health care costs and require price 
transparency.6 
 
1. HHS Secretary Statement on Executive Order to Put Patients in Control, 




2. See 2017 Comparative Price Report, INT’L FED’N OF HEALTH PLANS (Dec. 
2019), https://healthcostinstitute.org/images/pdfs/iFHP_Report_
2017_191212.pdf [https://perma.cc/PQ4Z-G9GE]. 
3. Margot Sanger-Katz, In the U.S., an Angioplasty Costs $32,000. 
Elsewhere? Maybe $6,400., N.Y. TIMES, (Dec. 27, 2019), 
https://www.nytimes.com/2019/12/27/upshot/expensive-health-care-
world-comparison.html [https://perma.cc/3APA-DLTV]. 
4. Jacqueline LaPointe, Price Transparency a Key Way States Control 
Healthcare Costs, REVCYCLEINTELLIGENCE, (Aug. 27, 2019), 
https://revcycleintelligence.com/news/price-transparency-a-key-way-
states-control-healthcare-costs [https://perma.cc/Q3C6-59VZ]. 
5. See Sanger-Katz, supra note 3. 
6. See Jacqueline LaPointe, Few States Have Robust Healthcare Price 
Transparency Laws, REVCYCLEINTELLIGENCE (May 11, 2020), 
https://revcycleintelligence.com/news/few-states-have-robust-
healthcare-price-transparency-laws [https://perma.cc/8UYZ-D23P]; 
Transparency of Health Costs: State Actions, NAT’L CONF. OF STATE 
LEGS., https://www.ncsl.org/research/health/transparency-and-
disclosure-health-costs.aspx [https://perma.cc/6FAF-FXHP]; Jim 
Stergios & Charlie Chieppo, Health Care Price Transparency Bill Would 
Be a Win For Taxpayers, Employers and Consumers, HILL (July 21, 2020 
6:00 EDT), https://thehill.com/blogs/congress-blog/healthcare/508417-
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As the United States’ health care expenditures continue to surge 
annually,7 price transparency has become a priority. Most American 
patients are unaware of what costs their insurance covers and what 
costs they must personally pay.8 These patients do not learn the cost 
amounts until the time of payment, making it difficult for them to make 
autonomous health care decisions.9 To combat this, the federal and 
state governments are trying to advance price transparency so that 
Americans may be the drivers of their health care treatment.10 For 
example, President Trump issued an executive order to emphasize the 
need to develop health care price transparency for patients.11 In 
addition, the Centers for Medicare and Medicaid also finalized rules, 
requiring hospitals and insurance companies to publish their retail 
prices online for patients.12 Moreover, several states passed laws to 
implement all-payer claims databases (APCDs), which collect health 
care pricing information to post on public websites.13 Nevertheless, there 
are disagreements among hospitals, economists, and other experts as to 
whether these various laws increase price transparency in a way that 




7. National Health Expenditure Fact Sheet, CTRS. FOR MEDICARE & 
MEDICAID (Dec. 5, 2019, 6:18 PM), https://www.cms.gov/Research-
Statistics-Data-and-Systems/Statistics-Trends-and-Reports/National
HealthExpendData/NHE-Fact-Sheet [https://perma.cc/H8C9-2DSP]. 
8. See Josh Archambault, Price Transparency Will Deliver Real Results for 




10. See id. 
11. See Exec. Order No. 13877, 84 Fed. Reg. 30,849 (June 24, 2019). 
12. Billy Wynne et al., A Look Inside The Hospital Transparency Final Rule, 
HEALTH AFFAIRS (Nov. 18, 2019), https://www.healthaffairs.org/
do/10.1377/hblog20191118.74200/full/ [https://perma.cc/879L-SQV5]; 
CTRS. FOR MEDICARE & MEDICAID SERVS., CMS-9915-F, TRANSPARENCY 
IN COVERAGE FINAL RULE FACT SHEET (2020). 
13. Roslyn Murray et al., The State of State Legislation Addressing Health 
Care Costs and Quality, HEALTHAFFAIRS (Aug. 22, 2019), 
https://www.healthaffairs.org/do/10.1377/hblog20190820.483741/full/ 
[https://perma.cc/T5G4-CERG]. 
14. See Thomas Sullivan, New Research Paper Indicates Price Transparency 
May Not Equate to Lower Prices, POL’Y & MED. (Aug. 26, 2020), 
https://www.policymed.com/2020/09/new-research-paper-indicates-
price-transparency-may-not-equate-to-lower-prices.html 
[https://perma.cc/642K-9EDB]; Benjamin Schwartz, The Problem With 
Pushing for Price Transparency, OP-MED (Feb. 18, 2020) 
https://opmed.doximity.com/articles/the-problem-with-pushing-for-
price-transparency [https://perma.cc/B4S5-UARC]; Sarah Kliff & 
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This Note proposes a new cost estimation system involving health 
care clearinghouses to act as translators between providers and payers. 
Clearinghouses may present each patient with an individualized, 
bundled cost estimate, combining all item and service costs as one 
estimate, prior to the patients receiving non-emergent medical care. A 
cost estimation system with clearinghouses has the potential to improve 
price transparency. This Note argues that price transparency laws are 
effective in protecting patients from high health care costs and allowing 
patients to make informed health care decisions as patients may 
evaluate cost estimates before any non-emergent medical treatment. 
Part II analyzes the effects of price transparency on the patients 
and health care prices. Part III provides background on federal efforts 
to reduce health care costs and encourage price transparency. Part IV 
discusses states’ use of all-payer claims databases to offer consumer-
friendly access to health care prices. Part V recommends a systematic 
process involving health care clearinghouses to improve price 
transparency among providers, payers, and patients. Finally, Part VI 
concludes clearinghouses as a tool to strengthen health care price 
transparency. 
I. Background on Health Care Price Transparency 
The Centers for Medicare and Medicaid Services (CMS) projects 
that the United States’ health spending will grow at an average rate of 
5.5% annually, reaching nearly $6 trillion by 2027.15 In 2018, the United 
States’ health expenditures grew by 4.6% to $3.6 trillion, accounting 
for 17.7% of the country’s gross domestic product (GDP).16 These 
statistics illustrate the urgency to evaluate and decelerate health care 
costs. 
Congress passed the Patient Protection and Affordable Care Act 
(ACA) in 2010 to expand the number of insured American health care 
 
Margot Sanger-Katz, Hospitals Sued to Keep Prices Secret. They Lost., 
N.Y. TIMES (June 23, 2020), https://www.nytimes.com/2020/
06/23/upshot/hospitals-lost-price-transparency-lawsuit.html 
[https://perma.cc/G9RN-NMPV]; Hannah Nelson, AHIP Issues 
Criticism on Final CMS Price Transparency Rule, HEALTH PAYER 
INTELLIGENCE (Nov. 5, 2020), https://healthpayerintelligence.com/
news/ahip-issues-criticism-on-final-cms-price-transparency-rule 
[https://perma.cc/J6XZ-3NT3]. 
15. CTRS. FOR MEDICARE & MEDICAID SERVS., NATIONAL HEALTH 
EXPENDITURE PROJECTIONS 2018–2027 (2019). 
16. Press Release, Ctrs. for Medicare & Medicaid Servs., CMS Office of the 
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consumers while improving health insurance affordability.17 However, 
President Obama emphasized that expanding insurance coverage 
without addressing the increasing healthcare costs would create an 
unsustainable healthcare system because federal and state governments 
would become bankrupt.18 The rising health care costs lay emphasis on 
the need for government intervention and price transparency. 
A. Effects of Price Transparency on Costs and Patients 
Price transparency exists when consumers have all the information 
concerning a good’s pricing.19 This also means there is no price 
discrimination in which different consumers are charged different 
prices.20 When price information is transparent, consumers know what 
they are expected to pay. Then, consumers can make sound cost 
comparisons of alternative options.21 Transparent prices are important 
to create an ideally free market with an efficient allocation of goods and 
services.22 Price transparency and cost comparisons pressure sellers to 
compete, and the increased competition may lower prices.23 If buyers 
can access and compare prices for the same good offered by different 
sellers, then the buyers may save money by selecting the cheaper 
product.24 If goods are similar but not the same, price transparency 
allows buyers to compare and buy what best suits them.25 Without 
market competition, sellers that are less efficient or earning excess 
profits can remain in the market, and prices remain higher than they 
would be if the market was competitive and efficient.26 
Health care price transparency provides consumers the ability to 
access provider-specific information on the prices of goods and services. 
Generally, health care consumers are particularly interested in out-of-
pocket costs because price transparency is not effective if patients 
consider irrelevant prices such as list prices, which are the costs before 
 
17. Christopher Limbacher, Healthcare Price Transparency: Reintroducing 
Competition, 53 HOUS. L. REV. 939, 941 (2016). 
18. Id. at 942. 
19. See D. ANDREW AUSTIN & JANE G. GRAVELLE, CONG. RESEARCH SERV., 
RL34101, DOES PRICE TRANSPARENCY IMPROVE MARKET EFFICIENCY? 
IMPLICATIONS OF EMPIRICAL EVIDENCE IN OTHER MARKETS FOR THE 
HEALTH SECTOR 1 (2007). 
20. Uwe E. Reinhardt, Health Care Price Transparency and Economic 
Theory, 312 JAMA 1642, 1642 (2014). 
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insurance companies cover a percentage.27 Out-of-pocket costs are the 
prices patients pay after the provider charges the insurance company,28 
and most American patients do not know their out-of-pocket costs until 
the time of payment.29 Therefore, they are unable to make cost-based 
health care decisions. Patients need good-faith, out-of-pocket price 
estimates before receiving treatment.30 
B. Support for Price Transparency 
Advocates believe patients deserve transparent health care pricing, 
and transparency is a solution to address the increasing health care 
expenditures. The main argument for increasing price transparency is 
that it will promote consumer-directed health care.31 If American 
patients are adequately informed, they may be able to better navigate 
the health care system and spend less money.32 Because most patients 
do not know the cost of their medical care until the time of payment, 
they are unable to make thoughtful, informed health care decisions.33 
According to national surveys, Americans want more information about 
prices while health care industry players are withholding information 
and resisting disclosure.34 Eighty-two percent of surveyed American 
voters claimed that they wished to know the cost of non-emergency 
procedures ahead of time.35 The questions that remain open are whether 
price transparency lowers health care costs and whether patients will 
understand the data. 
The patients who use the publicly-available pricing information and 
shop for services can save money and create “spillover effects” for other 
consumers.36 Price transparency tools generate “spillover effects” when 
consumers who did not shop for health care reap the benefits of lowered 
 
27. See Austin Frakt & Ateev Mehrotra, What Type of Price Transparency 
Do We Need in Health Care?, 170 ANNALS OF INTERNAL MED. 561, 561–
62 (2019). 
28. Out-of-Pocket Costs, HEALTHCARE.GOV, https://www.healthcare.gov/
glossary/out-of-pocket-costs/ [https://perma.cc/M8WP-R3C4]. 
29. LaPointe, supra note 4. 
30. Frakt & Mehrotra, supra note 27, at 562. 
31. See Reinhardt, supra note 20. 
32. Id. at 1643. 
33. Archambault, supra note 8. 
34. Id. 
35. Poll: Voters Want the Right to Shop for Health Care, FOUND. FOR GOV’T 
ACCOUNTABILITY (Jan. 29, 2018), https://thefga.org/poll/right-to-shop-
poll/ [https://perma.cc/7HYN-3X4R]. 
36. See Brian Blase, How Price Transparency Would Revolutionize 
Healthcare, N.Y. POST (Oct. 12, 2019 1:05 PM), https://nypost.com/
2019/10/12/how-price-transparency-would-revolutionize-healthcare/ 
[https://perma.cc/NNS6-5ZFT]. 
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prices created by those who shopped for services.37 For example, New 
Hampshire has a website that displays prices for medical services such 
as medical imaging, and individuals who shopped on the website saved 
about thirty-six percent of what the costs they would have paid if they 
had not used the website to compare prices.38 If more consumers become 
shoppers who evaluate the prices for medical services, expensive 
facilities will lower prices.39 
Most price transparency tools publish average or median hospital 
prices for individual services, which are not out-of-pocket costs.40 
Consumers must actively consider medical care prices in their 
decisions.41 A group of researchers studied consumers’ responses to price 
transparency, and the results confirmed that price transparency may 
increase competition and decrease health care costs if consumers are 
given strong financial incentives for price shopping.42 The researchers 
found that published health care prices alone produce limited success 
in terms of price shopping and increased competition.43 Patients need 
financial incentives to encourage them to price shop.44 On the other 
hand, if the costs to find and interpret data are high, then consumers 
have little incentive to compare costs.45 This research suggests that 
price transparency has the potential to increase competition and lower 
health care costs if patients are provided with incentives to assess health 
care prices. 
Lastly, health care price transparency advocates argue that 
providers and patients have a joint ethical responsibility to discuss 
medical costs to avoid financial harm to society.46 As the United States 
continues to endure rising health care costs, it would be unethical for 
physicians to allow patients to carry heavy financial health care 





40. Anna D. Sinaiko & Meredith B. Rosenthal, Increase Price Transparency 
in Health Care – Challenges and Potential Effects, 364 NEW ENG. J. OF 
MED. 891, 891 (2011). 
41. Id. at 893. 
42. Christopher Whaley et al., Consumer Responses to Price Transparency 
Alone Versus Price Transparency Combined With Reference Pricing, 5 
AM. J. OF HEALTH ECON. 227, 227 (2019). 
43. Id. at 246. 
44. Id. 
45. Id. 
46. Reshma Gupta et al., Promoting Transparency to Reduce Financial Harm 
to Patients, 17 AM. MED. ASS’N. J. OF ETHICS 1073, 1075 (2015). 
47. Id. 
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transparency and help avoid financial harm while promoting ethical 
medical practice.48 The promotion of price transparency to deliver high-
quality health care at lower costs is arguably part of physicians’ ethical 
duty to patients.49 
C. Criticism of Price Transparency 
Several critics argue against health care price transparency because 
patients rarely use price transparency tools.50 The American Journal of 
Managed Care published a study that surveyed more than 140 million 
health plan members across 31 different commercial plans who had 
access to price transparency tools.51 The researchers found that only 
two percent used the tools.52 They concluded that access to pricing tools 
does not increase the likelihood of using the tool, nor does it necessarily 
lead to lower costs.53 Thus, the researchers suggested additional inquiry 
to identify ways to better engage consumers and motivate them to make 
more informed and cost-effective decisions regarding their health care.54 
Another study investigated the relationship between employer-provided 
price information and outpatient spending.55 The Harvard Medical 
School researchers found that employees rarely used the provided 
information.56 Consequently, the researchers did not observe a reduction 
in health care costs.57 The rare use of price transparency tools supports 





50. Jacqueline LaPointe, How Healthcare Price Transparency Can Cuts 




51. Aparna Higgins et al., Characterizing Health Plan Price Estimator Tools: 
Findings From a National Survey, 22 AM. J. OF MANAGED CARE 126, 127 
(2016). 
52. Id. at 130. 
53. Id. 
54. Id. at 131. 
55. See Sunita Desai et al., Association Between Availability of a Price 
Transparency Tool and Outpatient Spending, 315 JAMA 1874 (2016). 
56. Id. at 1879. 
57. Id. 
58. See Rebecca A. Gourevitch et al., Who Uses a Price Transparency Tool? 
Implications for Increasing Consumer Engagement, 54 J. OF HEALTH 
CARE ORG., PROVISION, AND FINANCING 1–5 (2017). 
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Some argue that health care price transparency will ultimately 
increase costs.59 While economic theories suggest increasing price 
transparency will decrease health care costs, health care is considered 
an unusual economic sector that potentially disobeys economic rules.60 
Peter Ubel, a physician and behavioral scientist at Duke University, 
explained that public price information will enable providers to observe 
that competitors are charging higher prices, so providers may respond 
by raising their prices.61 Currently, most hospitals determine prices 
through confidential negotiations with insurers.62 If the negotiated 
prices become publicly available, providers will learn the prices charged 
by competitors.63 In other industries, similar transparency interfered 
with contract negotiations and caused higher prices, so there is concern 
that health care price transparency may produce a parallel effect.64 
Furthermore, price transparency tools may be considered ineffective 
because consumers misinterpret the provided information. A survey 
found that approximately half of the American population believes that 
higher quality health care generally comes at a higher cost while thirty-
seven percent claim there is no real relationship between quality and 
cost.65 Because some Americans believe that higher costs equate to 
higher quality, they are more likely to select higher-priced health care.66 
The implementation of price information tools may cause unintended 
higher prices because patients may intentionally opt for more expensive 
care. 
 
59. See Peter Ubel, How Price Transparency Could End Up Increasing 
Health-Care Costs, ATLANTIC (Apr. 9, 2013), 
https://www.theatlantic.com/health/archive/2013/04/how-price-
transparency-could-end-up-increasing-health-care-costs/274534/ 
[https://perma.cc/M3WZ-AGFV] (explaining how “[p]rice transparency 
may also cause prices to rise by reducing health-care providers’ willingness 
to bargain with insurance companies.”). 
60. David Blumenthal et al., Price Transparency in Health Care is Coming 
to the U.S. – But Will it Matter?, HARV. BUS. REV. (July 3, 2019), 
https://hbr.org/2019/07/price-transparency-in-health-care-is-coming-to-
the-u-s-but-will-it-matter [https://perma.cc/G6QL-99VL]. 
61. Ubel, supra note 59. 
62. Anna D. Sinaiko, What Is the Value of Market-Wide Health Care Price 
Transparency?, 322 J. OF AM. MED. ASS’N 1449, 1449 (2019). 
63. Id. 
64. Id. 
65. THE ASSOCIATED PRESS NAT’L OPINION RES. CTR., FINDING QUALITY 




66. Blumenthal et al., supra note 60. 
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Additionally, as previously noted, patients are only concerned 
about out-of-pocket payments.67 For instance, two different patients 
paying for the same medical test may both pay $150 out-of-pocket 
although each individual’s insurance company may cover different 
amounts. If patients are paying the same out-of-pocket price, they do 
not have any incentive to compare or shop for another medical test that 
is cheaper based on list pricing.68 
Several analysts are skeptical regarding the possible effects of price 
transparency because they fear hospital prices may become lower, but 
the costs will shift elsewhere.69 If health care costs shift from hospital 
charges to payments for insurance, consumers will still pay for the 
redistributed health care costs.70 In other words, consumers may pay 
less for hospital charges but more for insurance coverage. Others 
question whether hospital-provided health care is shoppable because 
patients often do not have incentives to consider different providers.71 
Patients typically trust their doctors’ opinions and orders, so they 
would not have an incentive to obtain a second opinion, especially for 
non-emergent or routine medical services. Critics generally question the 
effectiveness of publishing prices because calculated health care costs 
are complex and unique to each patient.72 
In health care markets, consumers often have difficulty finding 
useful price information for hospital stays, operations, or prescription 
drugs.73 Because hospitals charge significantly different prices, some 
argue that price transparency would cause the health care market to be 
more efficient.74 Conversely, others claim the health care market is 
 
67. Frakt & Mehrotra, supra note 27, at 561. 
68. Ubel, supra note 59. 
69. Arlene Weintraub, Will President Trump’s Hospital Price Transparency 






72. See E. John Steren & Patricia M. Wagner, Will Price Transparency 
Benefit Consumers or Facilitate Antitrust Violations?, NAT’L L. REV. 
(Oct. 31, 2019), https://www.natlawreview.com/article/will-price-
transparency-benefit-consumers-or-facilitate-antitrust-violations 
[https://perma.cc/ED5K-CH39]; Reed Abelson & Margot Sanger-Katz, A 
New Trump Order May Make More Health Care Prices Public, N.Y. 
TIMES (June 24, 2019), https://www.nytimes.com/
2019/06/24/upshot/health-care-price-transparency-trump.html 
[https://perma.cc/6T27-RUKN]. 
73. See AUSTIN & GRAVELLE, supra note 19. 
74. Id. at CR-33. 
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unique and cannot be compared to markets for “shoppable” goods.75 
Critics claim health care price transparency tools are ineffective and 
may instead contribute to rising health care costs.76 Despite opposition 
to health care price transparency tools, research suggests that the tools, 
combined with consumers’ financial incentives to compare prices, may 
produce desired market competition and lower health care costs.77 
Therefore, price transparency provides more benefits than harm to 
consumers and patients, supporting the federal and state governments’ 
actions to increase health care price transparency. 
II. Federal Efforts: Price Transparency Final Rules 
The American federal government asserts that increased healthcare 
price transparency enables consumers to make fully-informed health 
care decisions.78 On June 24, 2019, President Trump signed the 
“Executive Order Improving Price and Quality Transparency in 
American Healthcare to Put Patients First.”79 The executive order 
instructs the Department of Health and Human Services (HHS) to 
develop a policy and draft new rules80 to ensure that patients possess 
basic information to actively select their preferred or necessary health 
care.81 The order also discusses the need to incentivize consumers to 
search for and evaluate health care cost information to compare 
“shoppable” services’ prices.82 Because many consumers do not know 
what their out-of-pocket expenses will be until they receive notice from 
their insurance company explaining hospital charges, the federal 
government seeks to investigate methods to make negotiated discounts 
and patients’ costs more available.83 This is important to patients since 
 
75. Weintraub, supra note 69. 
76. Tamara Keith & Selena Simmons-Duffin, Trump Administration Pushes 




77. See Whaley et al., supra note 42. 
78. See Exec. Order No. 13877, 84 Fed. Reg. 30,849, 30,849 (June 24, 2019). 
79. Id. 
80. Katie Keith, Unpacking The Executive Order On Health Care Price 
Transparency And Quality, HEALTHAFFAIRS (June 25, 2019), 
https://www.healthaffairs.org/do/10.1377/hblog20190625.974595/full/ 
[https://perma.cc/N4LL-8V97]. 
81. See Exec. Order No. 13877, 84 Fed. Reg. 30,849, 30,850 (June 24, 2019). 
82. “‘[S]hoppable’ services (common services offered by multiple providers 
through the market, which patients can research and compare before 
making informed choices based on price and quality).” Id. at 30,849. 
83. Id. 
Health Matrix·Volume 31·2021 
A Key to Clarity 
420 
they typically do not have concerns about list prices but rather about 
their out-of-pocket costs after insurance coverage.84 Marni Jameson 
Carey, executive director of the Association of Independent Doctors, 
responded to the executive order stating, “[r]eal price transparency is 
the first, and single most important step toward fixing America’s 
broken, over-priced health-care system.”85 The federal government aims 
to eliminate unnecessary barriers to price transparency and increase the 
availability of meaningful price information for patients to boost their 
control over their health care resources.86 
A. Inpatient Prospective Payment System Final Rule 
On January 1, 2019, the Centers for Medicare and Medicaid’s Fiscal 
Year 2019 Inpatient Prospective Payment System (IPPS) final rule 
became effective.87 The price transparency part of the IPPS final rule 
requires hospitals to publish and annually update “machine readable” 
chargemasters, or lists of hospitals’ standard charges for individual 
items and services.88 Standard charges are the prices hospitals set for a 
provided service or item before negotiating any discounts or billing 
payers and patients.89 Some hospitals clearly publish their charges on 
their websites while others post incomprehensible price data.90 
CMS requires hospitals to publish hospital price data, and most 
hospitals mention this on their chargemaster webpages.91 Hospitals also 
warn that the charges do not represent a patient’s out-of-pocket costs 
 
84. Keith, supra note 80. 
85. Healthcare Industry Experts Praise White House Executive Order On 




86. See Exec. Order No. 13877, 84 Fed. Reg. 30,849, 30,850 (June 24, 2019). 
87. Wynne et al., supra note 12. 
88. 83 Fed. Reg. 41,144, 41,686 (Aug. 17, 2018). 
89. ASS’N OF AM. MED. CS., PRICE TRANSPARENCY: COMMON DEFINITIONS, 
https://www.aamc.org/system/files/c/2/450000-pricetran_
commondefs.pdf [https://perma.cc/2QUA-8GU4]. 
90. Harris Meyer, Hospitals Vary in Publishing CMS Chargemaster 




91. See Chargemaster, NW. MED., https://www.nm.org/patients-and-visitors
/billing-and-insurance/chargemaster [https://perma.cc/W7G4-7LQG]; 
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but rather the amount the hospital would charge an insurer.92 
Therefore, patients should talk to their insurance providers to know 
how much they would be expected to pay, in other words, their out-of-
pocket costs.93 Typically the chargemasters consist of thousands of rows 
listing services, medications, and surgical supplies along with the 
respective prices.94 The data set is overwhelming and difficult for a 
layperson to understand.95 For example, one may find “Glucose Body 
Fluid” for $90 or “2.4 Pins” for $105, but what does that mean?96 If 
patients wanted to look through the pricing spreadsheets with the hope 
of determining approximately how much a hip replacement would cost, 
they would likely struggle to calculate a cost estimate because the 
patients likely would not be able to identify all the necessary 
medications or supplies to add up a cost estimate for the service. Even 
if they figured out what to add together, they would not know the 
applicable out-of-pocket cost because hospitals list standard charges.97 
Critics argue that the IPPS final rule requirements are useless and 
misleading for consumers because the hospitals’ price data are not 
personalized cost estimates.98 Out-of-pocket prices depend on an 
individual’s health plan benefits and deductible status.99 Therefore, 
posting chargemasters would not achieve the goal of driving down 
health care costs because they are not the most effective way to change 
consumers’ behaviors in the health care market.100 Conversely, HHS 
Secretary, Alex Azar, and CMS Administrator, Seema Verma, claim 
that these requirements foster price transparency for medical services, 
prescription drugs, and health plans.101 They believe the published 
hospital chargemasters are stepping stones to address rising healthcare 
costs and inform patients about the cost in healthcare.102 
Azar and Verma make valid claims with their beliefs that hospital 
chargemasters improve healthcare price transparency for patients. 
While the IPPS Final Rule requires hospitals to provide patients access 
 
92. NW. MED., supra note 91. 
93. Id. 
94. See Id. (cited material is available through selecting links). 
95. Reinhardt, supra note 20. 




97. See Reinhardt, supra note 20, at 1642-43. 
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to review costs, the chargemasters do not offer understandable or 
relevant prices for the patients. Therefore, the IPPS Final Rule would 
likely be ineffective to expand health care price transparency in a way 
that helps patients to know costs before treatment or make their own 
decisions that may affect the health care market and its prices. 
B. Outpatient Prospective Payment System Final Rule 
On November 15, 2019, CMS finalized the Outpatient Prospective 
Payment System (OPPS) final rule.103 The OPPS final rule expanded 
on the IPPS final rule by providing hospitals with more specific 
guidance for publishing price information online.104 The rule’s goal is to 
continue promoting health care price transparency with publicly 
accessible hospital standard charges.105 Starting on January 1, 2021, 
hospitals are required to continue posting a consumer-friendly, 
comprehensive, machine-readable file for all their charges and post at 
least 300 shoppable services such as magnetic resonance imaging (MRI) 
scans and x-rays.106 Failure to do so may result in a fine of $300 per 
day.107 The Department of HHS and CMS believe that hospitals’ 
compliance with these requirements will allow patients to make more 
informed health care decisions.108 Likewise, if patients are more aware 
of various hospitals’ charges, then the chargemasters may achieve the 
ultimate goals of increasing market competition and lowering costs.109 
Compared to the IPPS final rule, the possible fines charged to hospitals 
for failing to publish price information online may result in compliance 
and action from the hospitals. However, the IPPS and OPPS final rules 
 
103. CTRS. FOR MEDICARE & MEDICAID SERVS., CY 2020 HOSPITAL 
OUTPATIENT PROSPECTIVE PAYMENT SYSTEM (OPPS) POLICY CHANGES: 
HOSPITAL PRICE TRANSPARENCY REQUIREMENTS (CMS-1717-F2) (Nov. 
15, 2019), https://www.cms.gov/newsroom/fact-sheets/cy-2020-hospital-
outpatient-prospective-payment-system-opps-policy-changes-hospital-
price [hereinafter HOSPITAL OPPS POLICY CHANGES] 
[https://perma.cc/7F3W-S2LJ]. 
104. Id. 
105. DEP’T OF HEALTH AND HUMAN SERVICES, MEDICARE AND MEDICAID 
PROGRAMS: CY 2020 HOSPITAL OUTPATIENT PPS POLICY CHANGES AND 
PAYMENT RATES AND AMBULATORY SURGICAL CENTER PAYMENT SYSTEM 
POLICY CHANGES AND PAYMENT RATES. PRICE TRANSPARENCY 
REQUIREMENTS FOR HOSPITALS TO MAKE STANDARD CHARGES PUBLIC 
(Nov. 7, 2019), https://www.hhs.gov/sites/default/files/cms-1717-f2.pdf 
[hereinafter Medicare and Medicaid]; See also U.S. DEP’T HEALTH & HUM. 
SERVS. Medicare and Medicaid Programs Rule, 45 C.F.R. pt. 180 (2021). 
106. CTRS. FOR MEDICARE & MEDICAID SERVS., supra note 103. 
107. Medicare and Medicaid, supra note 105. 
108. Id. 
109. Id. 
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bring forward debatable concerns about the effectiveness of the rules 
for patients to look up health care costs. 
C. Responses to the IPPS and OPPS Final Rules 
When the OPPS final rule was open for public comment, hospitals 
and insurers reacted to the proposal.110 They claimed that the vast 
amounts of public price data online will overwhelm consumers instead 
of helping them better understand health care costs.111 Furthermore, 
hospitals and insurers argued that compliance with the rule would 
require disclosure of trade secrets, encumber price negotiations between 
providers and payers, and adversely raise prices.112 Larry Levitt, 
Executive Vice President of the Kaiser Family Foundation, mentioned 
that the penalty for the transparency rule is weak, and hospitals would 
likely rather pay $300 a day than publish massive amounts of data on 
negotiated prices in addition to updating the data annually.113 Hospitals 
have a greater incentive to protect what they consider proprietary 
information.114 
Additionally, since CMS issued the OPPS final rule, hospitals have 
been concerned that the availability of chargemaster information will 
only hinder consumers from accessing appropriate health care.115 
Hospitals claim that patients may be overwhelmed and confused by the 
data and hinder patients from seeking appropriate medical care.116 
Shortly after the rule’s release, four hospital organizations sued HHS 
for violating the First Amendment, challenging HHS’s statutory 
authority to require public disclosure of negotiated retail prices between 
insurers and hospitals.117 
 
110. Selena Simmons-Duffin, Trump Wants Insurers and Hospitals To Show 




111. Julie Appleby, White House Unveils Finalized Health Care Price 




113. Simmons-Duffin, supra note 110. 




115. Wynne et al., supra note 12. 
116. Id. 
117. Ayla Ellison, Hospital Groups Sue HHS to Block Price Transparency 
Rule, BECKER’S HOSP. REV. (Dec. 4, 2019), 
https://www.beckershospitalreview.com/legal-regulatory-issues/hospital-
groups-sue-hhs-to-block-price-transparency-rule.html 
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Rick Pollack, President and CEO of the American Hospital 
Association, commented, “[i]nstead of giving patients relevant 
information about costs, this rule will lead to widespread confusion and 
even more consolidation in the commercial health insurance industry. 
We stand ready to work with CMS and other stakeholders to advance 
real solutions for patients.”118 Pollack is concerned that patients will not 
use the chargemasters. Instead, the available data may incentivize 
health insurance companies to merge since the mandated price 
disclosure interferes with the price negotiations between hospitals and 
insurance companies.119 Merging would allow health insurers to gain 
market power in an already heavily concentrated market and influence 
prices.120 
On June 23, 2020, the United States District Court for the District 
of Columbia granted HHS’s Motion for Summary Judgment against the 
hospital associations.121 Judge Nichols found that the OPPS final rule 
was legal to require disclosure of hospital charges and the hospitals were 
trying to limit patients’ access to medical prices.122 The hospital 
associations immediately appealed to overturn the upholding of the 
OPPS final rule.123 On December 29, 2020, the United States Court of 
Appeals for the District of Columbia Circuit affirmed the District 
 
[https://perma.cc/ZNT9-UNXD]; Reed Abelson, Hospitals Sue Trump to 
Keep Negotiated Prices Secret, N.Y. TIMES (Dec. 4, 2019), 
https://www.nytimes.com/2019/12/04/health/hospitals-trump-prices-
transparency.html [https://perma.cc/EG35-UZVH]. 
118. Ellison, supra note 117. 
119. John Commins, Price Transparency Is Coming. How Will You Prepare?, 
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Transparency Rule, POLICYMED (June 28, 2020), 
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Court’s rejection of hospitals’ challenge to the rule.124 Thus, hospitals 
must prepare to disclose pricing information as CMS announced plans 
to start auditing hospitals and enforcing compliance in January 2021.125 
D. Transparency in Coverage Final Rule 
On October 29, 2020, CMS finalized the Transparency in Coverage 
final rule.126 Unlike the previous final rules that focus on hospitals, this 
final rule requires certain group health plans and health insurance 
issuers to disclose patient pricing information.127 The final rule requires 
payers to make the information available through an online, self-service 
tool or paper form if requested.128 The rule’s purpose is to provide 
patients with estimates and an understanding of their out-of-pocket 
expenses so that the patients may efficiently shop for medical items and 
services.129 The Transparency in Coverage final rule also requires plans 
and issuers to disclose negotiated rates of in-network providers, 
historical, allowed out-of-network amounts, and drug pricing 
information on an internet website.130 The Transparency in Coverage 
final rule aims to reduce secrecy behind health care costs and increase 
competition within the private health care industry. 131 
Although the Transparency in Coverage final rule has only recently 
been published, criticism has already come to light. America’s Health 
Insurance Plans (AHIP) came forward with claims arguing that 
publishing privately negotiated rates would reduce incentives to offer 
lower rates during future negotiations, which would raise premium 
prices.132 On the other hand, consumer advocates applaud the new final 
rule as a significant step to increase price transparency, supporting 
consumers to make more price-conscious decisions and prevent 
 
124. See AHA, 2020 WL 7703008. 
125. CTRS. FOR MEDICARE & MEDICAID SERVS., MONITORING FOR HOSPITAL 
PRICE TRANSPARENCY (2020), https://www.cms.gov/outreachand
educationoutreachffsprovpartprogprovider-partnership-email-archive/
2020-12-18-mlnc-se [https://perma.cc/6KU8-CD38]. 
126. CTRS. FOR MEDICARE & MEDICAID SERVS., CMS-9915-F, TRANSPARENCY 
IN COVERAGE FINAL RULE FACT SHEET (2020). 
127. Kelsey Wadill, CMS Finalizes Price Transparency Rule with Self-Service 
Tool, HEALTH PAYER INTEL. (Oct. 29, 2020), 
https://healthpayerintelligence.com/news/cms-finalizes-price-
transparency-rule-with-self-service-tool [https://perma.cc/Z752-FUE2]. 
128. 85 Fed. Reg. 72,158, 72,158 (Nov. 12, 2020). 
129. CTRS. FOR MEDICARE & MEDICAID SERVS., supra note 126. 
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uninformed or excessive price increases.133 The responses received thus 
far regarding the Transparency in Coverage final rule reflect the key 
arguments in the debate about price transparency as anticipated and 
discussed in Section II. The Transparency in Coverage final rule 
requires action starting at various points between 2022 and 2024.134 
III. State Efforts for Price Transparency 
As health care costs continue to increase, states have been 
prioritizing the passage of new laws concerning health care prices.135 
One area of focus has been improving price transparency.136 Eighteen 
states created laws to establish all-payer claims databases (APCDs), 
which collect health care price and quality information.137 Eight states 
have websites that make price and quality information available to the 
public.138 APCDs usually post providers’ list prices, the total amounts 
a provider expects to be paid for the health care services, instead of the 
out-of-pocket amounts.139 The more effective APCDs allow consumers 
to go on a website to view and compare provider- and plan-specific price 
estimates.140 
 
133. Joe Records & Michelle Chipetine, HHS Finalizes Health Plan Price 
Transparency Rule, C&M HEALTH L. (Nov. 23, 2020), 
https://www.cmhealthlaw.com/2020/11/hhs-finalizes-health-plan-price-
transparency-rule/ [https://perma.cc/VF7W-PKHC]. 
134. CTRS. FOR MEDICARE & MEDICAID SERVS., supra note 126. 
135. MURRAY, supra note 13. 
136. Id. 
137. All-Payer Claims Databases, AGENCY FOR HEALTHCARE RES. AND 
QUALITY, https://www.ahrq.gov/data/apcd/index.html 
[https://perma.cc/4UAF-8MEP]. 
138. Murray et al., supra note 13. 
139. Erin C. Fuse Brown & Jaime S. King, ERISA as a Barrier for State 
Health Care Transparency Efforts, in TRANSPARENCY IN HEALTH AND 
HEALTH CARE IN THE UNITED STATES: LAW AND ETHICS 301, 302 (2019). 
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A. All-Payer Claims Databases (APCDs) 
Many states established APCDs to provide transparent information 
for patients to compare prices.142 APCDs combine data from all payers 
in a state and give state policymakers information on costs, quality, 
utilization patterns, access and barriers to care, and other health care 
measures.143 The National Association of Health Data Organizations 
(NAHDO) and the Regional All Payer Healthcare Information Council 
(RAPHIC) define APCDs as “databases, created by state mandate, 
that typically include data derived from medical claims, pharmacy 
claims, eligibility files, provider files, and dental claims from private 
and public payers. In states without a legislative mandate, there may 
be voluntary reporting of these data.”144 States are voluntarily and 
legally mandating APCDs as sources for transparency to reform health 
care activities.145 States use APCDs to evaluate health care costs and 
provide state stakeholders with information about health care 
 
141. The APCD Council’s website presents a visual map of states and their 
status regarding APCDs. Interactive State Report Map, ALL-PAYER 
CLAIMS DATABASE COUNCIL, https://www.apcdcouncil.org/state/map 
[https://perma.cc/AEY9-V6F3]. 
142. Denise Love et al., All-Payer Claims Databases: State Initiatives to 
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utilization patterns, in addition to identifying state needs.146 Overall, 
APCDs allow states to have a foundation to evaluate reform efforts and 
understand the health care provided to their citizens.147 
More states are implementing APCDs by law each year.148 There 
are altogether over 30 states maintaining, developing, or showing strong 
interest in establishing an APCD.149 States with websites use APCD 
data to present cost information to consumers.150 As APCDs combine 
data from all state payers and make them publicly available, consumers 
have tools to compare prices to make health care decisions.151 
An individual can access Maine’s APCD on the CompareMaine 
website to find the cost of a procedure.152 On CompareMaine, a patient 
can select or search for a particular procedure and view its average cost 
along with a list of facilities that provide the procedure in Maine and 
their prices.153 The patient can narrow down the results by restricting 
the location radius or sorting priorities such as the average total cost 
from low to high or high to low.154 Other sorting categories are the 
hospitals’ ratings concerning patient experience or the prevention of 
serious complications.155 Regarding cost breakdown, CompareMaine 
shows how a price is split between the facility and professional service 
costs, meaning the amounts the hospitals and the service-providers 
charge for the procedure.156 Maine’s APCD also provides the estimated 
number of times the facility performs the procedure.157 APCDs are 
generally more consumer-friendly than chargemasters because the 
 
146. Id. 
147. Jo Porter et al., The Basics of All-Payer Claims Databases, 2014 ROBERT 
WOOD JOHNSON FOUND.: STATE HEALTH AND VALUE STRATEGIES 7 (2014). 
148. Id. at 1. 
149. AGENCY FOR HEALTHCARE RES. AND QUALITY, supra note 137. 
150. Id. See N.H. COMPREHENSIVE HEALTH CARE INFO. SYS., 
https://nhchis.com/ [https://perma.cc/JR5Y-9RFZ]; Compare the Costs 
& Quality of HealthCare Procedures in Maine, COMPARE ME., 
https://www.comparemaine.org [https://perma.cc/T5L2-DMPZ]; see 
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ANALYSIS, https://www.chiamass.gov/our-data/ 
[https://perma.cc/C3SE-4KRZ]. 
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152. See COMPARE ME., supra note 150. 
153. Id.; see, e.g., Electrocardiogram, COMPARE ME., 
https://www.comparemaine.org/?page=report&procedure=93005 
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APCD websites are easier to navigate as they are reminiscent of typical 
online shopping. However, patients still lack out-of-pocket cost 
estimates, which matter most to patients. 
APCDs improve price transparency in the sense that patients may 
have a better, general idea of the charge for a medical service before its 
occurrence. APCDs can be valuable as they allow access to data for 
healthcare stakeholders seeking information for research, policymaking, 
and purchasing activities, but as with other vast data sets, there are 
concerns regarding APCDs.158 
B. Shortcomings of APCDs 
The major shortcoming of APCDs is that consumers will not know 
their estimated out-of-pocket costs or deductible status after scanning 
a state’s APCD website.159 One study evaluated how to improve state 
health care price transparency websites.160 The researchers asserted that 
APCDs may be more relevant and effective for patients if the published 
prices are for predictable, non-urgent services, rather than 
unpredictable, emergent services like surgeries or hospitalizations for 
life-threatening conditions.161 This is likely because patients would not 
have time or anticipate to use an APCD to analyze prices for emergency 
medical treatment compared to a scheduled service. Moreover, states 
may improve price transparency if the APCDs report cost estimates for 
full episodes of care.162 Specifically, patients may view one cost estimate 
with a breakdown of the aggregated prices, including all facility, 
professional, and other fees.163 These added factors improve health care 
price transparency.164 
The majority of states have legally mandated or voluntarily 
established APCDs to offer their citizens tools to make health care 
prices more transparent.165 Although some states post list prices that 
are not useful to consumers who are more concerned about out-of-
pocket expenses, well-implemented APCDs provide specific cost 
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estimates based on patients’ providers and insurance plans.166 APCDs 
improve price transparency in the sense that patients may have a better 
idea of how much they are expected to pay for a medical service prior 
to its occurrence. But, there is debate as to whether the APCDs’ 
published price data enable patients to make independent health care 
decisions, ultimately increasing market competition and decreasing 
costs. 
IV. Recommendation: Health Care Clearinghouses 
The federal and state governments are attempting to combat rising 
health care costs with price transparency. However, the APCDs and 
requirements to publish hospitals’ prices have been minimally helpful 
for consumers and highly opposed by hospitals and insurers.167 Although 
the OPPS final rule will impose stricter requirements, the published 
prices would not be consumer-specific but rather standard charges.168 
For health care consumers to receive a valuable cost estimate, the 
necessary elements to consider are: (1) the specific diagnosis and 
treatment for which they will be billed; (2) the contracted rate between 
their insurer and provider; and (3) where on the spectrum of deductibles 
and out-of-pocket maximums they will be when provided service. Then, 
a consumer may calculate a more accurate cost estimate by combining 
the provider’s price with the consumer’s current insurance status.169 
This Note proposes to create a process involving medical claims 
clearinghouses that would produce specific cost estimates for consumers 
seeking prices for non-emergent medical expenses. 
A. Current Health Care Clearinghouse Process 
A clearinghouse is a third-party that interprets data, acting as a 
middleman between the provider and the payer.170 A health care 
clearinghouse is defined as a public or private entity that changes health 
information from a nonstandard format to standard data elements to 
produce cost estimates.171 Clearinghouses are covered entities under the 
 
166. Brown & King, supra note 139, at 302–03. 
167. See supra Sections III and IV. 
168. See supra Section III.D. 
169. See U.S. GOV’T ACCOUNTABILITY OFF., GAO-11-791, HEALTH CARE PRICE 
TRANSPARENCY: MEANINGFUL PRICE INFORMATION IS DIFFICULT FOR 
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170. What is a Healthcare Clearinghouse & Why Use One?, NEARTERM (Aug. 
21, 2018), https://nearterm.com/what-is-a-healthcare-clearinghouse-
medical-billing-electronic-claims/ [https://perma.cc/EJ98-QEVZ]. 
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Health Insurance Portability and Accountability Act (HIPAA) and 
subject to strict standards.172 Therefore, the transmissions of medical 
claims between providers, clearinghouses, and payers are secure patient 
health information.173 Generally, a clearinghouse takes electronic 
medical claims’ information, strips the data to create an estimate, and 
then submits information electronically to the contracted insurance 
company.174 When clearinghouses “strip” or “scrub” the claim to 
translate the data from nonstandard to standard elements, 
clearinghouses check the claim for errors and verify the data is 
compatible with the payer software to produce the costs.175 The 
clearinghouse also ensures that the procedural and diagnosis codes are 
valid and that each procedure code is appropriate for the diagnosis code 
submitted with it.176 
The typical clearinghouse process starts when a patient visits the 
doctor, who then diagnoses the patient and provides the treatment.177 
The provider’s administrators then send the medical claim to the 
patient’s medical billing clearinghouse account.178 The medical 
clearinghouses have contracts with and are trained by insurance 
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from another entity in a nonstandard format or containing nonstandard 
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companies.179 The clearinghouses have the patient’s information for the 
particular claim, such as medical history, insurance plan, and insurance 
status, from the insurance companies.180 After receiving a medical claim, 
the clearinghouse scrubs or checks the claim for errors and translates 
the claim to a “standard data form,” which is a special data coding 
language to calculate a cost. When the claim passes inspection, the 
clearinghouse produces a cost breakdown and securely sends the 
electronic claim to the appropriate payer, such as a private health 
insurance company.181 At this point, the payer typically accepts or 
denies the claim.182 The payer receives the cost breakdown and pays its 
portion.183 Then, the provider charges the patient for the rest of the 
claim, or the out-of-pocket cost.184 
 
 
B. Proposal: Clearinghouses for Cost Estimation 
For non-emergent health care, clearinghouses can be useful entities 
to provide patients with individualized, specific cost estimates and 
improve price transparency. Clearinghouses can consider the nature of 
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Health Matrix·Volume 31·2021 
A Key to Clarity 
433 
a patient’s claim based on submitted information to determine how 
much the insurer and patient will pay respectively. I propose that 
clearinghouses be involved in a process before a patient receives a 
medical service. My proposal also includes aggregators that are 
currently not a part of any medical billing process but would be 
separately contracted with hospitals. The process is most functional and 
efficient with both aggregators and clearinghouses because hospitals 
would pay and contract with aggregators. Meanwhile, insurance 
companies pay and contract with clearinghouses. As will be further 
discussed in this section, aggregators and clearinghouses have different 
functions and access to information based on their contracted 
relationships. However, together, aggregators and clearinghouses have 
the potential to create an efficient and helpful cost estimation process 
to improve health care price transparency. The cost estimate process I 
propose does not apply to emergency health care situations because 
there would not be enough time to receive cost estimates as doctors 
make quick decisions. 
First, a patient will visit the doctor who will order a future 
procedure. A patient may go online to an aggregator’s website. Because 
an aggregator is separately contracted with hospitals, the patient will 
not have to pay anything to the aggregator because it receives 
commissions from the hospitals. On the aggregator’s website, the 
patient may submit a request for proposal (RFP). This would require 
the patient to answer several questions concerning the specific 
procedure or service, location, hospital preferences, and insurance plan, 
which includes the specific clearinghouse contracted with an 
individual’s insurer. The aggregator will attain bids or determine list 
prices from hospitals within the RFP specifications. The aggregator 
then sends all the information to the clearinghouse. 
The clearinghouse can apply the patient’s information and 
insurance plan to the hospitals’ prices and break down the costs to what 
the insurance company would cover and what would be the patient’s 
out-of-pocket costs. The clearinghouse sends the cost estimates back to 
the aggregator. Finally, the aggregator forwards the patient a list of 
hospitals and bundled out-of-pocket cost estimates for the ordered 
procedure based on the patient’s insurance plan and status. The cost 
estimates are bundled as each estimate includes all service, equipment, 
and medication fees. This cost estimate process with a health care 
clearinghouse allows patients to have a better, personalized idea of what 
they will pay after receiving the medical treatment. Patients may also 
decide to receive a second opinion from another provider. 
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C. Advantages of Clearinghouses 
Clearinghouses have several advantages that contribute to health 
care price transparency. First, clearinghouses will provide patients with 
personal cost estimates based on their insurance information. 
Clearinghouses can also bundle all the medical claims together so that 
patients receive one cost estimate for the medical procedure and all 
other drugs or hospital charges instead of processing them separately. 
Secondly, clearinghouses will create a more efficient cost estimation 
process as they simplify and speed up the process for consumers. 
Patients will not have to find complicated pricing data published online. 
In fact, patients will not have to do much work besides inputting data 
based on personal preferences and insurance information. Since the 
process is done electronically using expert software systems, 
clearinghouses can produce estimates and send them in a short amount 
of time. 
Also, clearinghouses are third parties that will protect the patients’ 
information and provide unbiased cost estimates because clearinghouses 
are middlemen between the providers and payers that are legally bound 
by HIPAA. Broadly considered, clearinghouses may reduce errors and 
expose hidden costs charged by providers due to improved price 
transparency between all parties.185 Involving clearinghouses offers 
significant improvements to health care price transparency for patients, 
but difficult challenges remain. 
D. Concerns of Clearinghouses 
While a health care cost estimation process involving clearinghouses 
will improve price transparency, important questions remain about cost 
coverage and whether the price transparency will ultimately lower 
health care costs. Insurance companies pay for clearinghouse services in 
 
185. See Best Practices in Patient Cost Estimation, MICROMD (Dec. 11, 2018), 
https://www.micromd.com/enotes/best-practices-in-patient-cost-
estimation/; Prasad, supra note 174. 
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the current medical billing process involving clearinghouses.186 Insurers 
should continue to contract with and pay for clearinghouses. An 
implementation of a new cost estimation feature in the medical billing 
process will already create necessary adjustments, so the insurance 
companies remaining as contractors and payers for medical 
clearinghouses’ services will minimize the complexity of the new cost 
estimation process. 
Another concern is whether the clearinghouses would estimate costs 
for all types of providers and services. Clearinghouses typically work 
with all types of providers including large hospitals and private doctors’ 
offices.187 Because clearinghouses already handle all types of medical 
claims for services such as surgical procedures or therapy, both in and 
out of an insurance company’s network, clearinghouses should be able 
to provide cost estimates for a vast range of providers and services. 
The ultimate question is whether the cost estimation process 
performed by clearinghouses will promote price transparency for 
patients and produce the desired reduction in health care costs. If 
insurers continue to cover the clearinghouses’ services, patients will 
likely pay more for their insurance since clearinghouses will provide 
additional services for cost estimation. A major concern is whether 
insurance companies may force patients to select the cheapest provider 
because the insurance company is paying for the clearinghouse’s 
services. Although this is a valid concern, it should not be a substantial 
issue. Based on how insurance companies and providers interact today, 
insurance companies already know the various prices charged as they 
negotiated and set the rates with the providers.188 Insurance companies 
provide patients with freedom of choice. In addition, the insurance 
companies’ coverage of clearinghouses’ services raises the issue that the 
costs will shift or increase because patients will have to pay for more 
expensive insurance on top of rising health care costs. There is also 
uncertainty whether this method of price transparency will lower health 
 






187. What is a Healthcare Clearinghouse & Why Use One?, NEARTERM BLOG 
(Aug. 21, 2018), https://nearterm.com/what-is-a-healthcare-
clearinghouse-medical-billing-electronic-claims/ [https://perma.cc/8T8K-
QRXY]. 
188. See Philip Moeller, 3 Problems That Are Spiking Health Care Costs, 
According To This Surgeon, PBS NEWSHOUR: MAKING SENSE (Sept. 11, 
2019, 6:03 am), https://www.pbs.org/newshour/economy/making-sense
/3-problems-that-are-spiking-health-care-costs-according-to-this-surgeon 
[https://perma.cc/33GS-99C3] (discussing disclosure of costs that 
“insurers and providers agree upon”). 
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care costs. Although patients may pay more for insurance in the short 
run, in the long run, this cost estimation process with clearinghouses 
would overall likely improve price transparency and provide patients 
the opportunity to shop for health care services and lower health care 
costs. 
Conclusion 
Health care clearinghouses may be the solution to place patients in 
the driver’s seat when it comes to their health care decisions. 
Clearinghouses will release patients from the burden of analyzing online 
pricing data and instead provide patients with straightforward cost 
estimates that are specific to their insurance circumstances. The 
implementation of a cost estimation process with health care 
clearinghouses is complex. However, clearinghouses have the potential 
to create the price transparency sought between health care providers 
and patients, specifically for non-emergency medical circumstances. My 
recommendation is to establish a broad framework involving health care 
clearinghouses for a cost estimation system to improve price 
transparency. Further research and cost-benefit analysis are necessary 
to determine how to implement such a process. Nonetheless, if health 
care clearinghouses provide patients with individualized cost estimates 
and incentivize Americans to compare health care prices, then 
clearinghouses may substantially improve health care price 
transparency and reduce surging health care costs. 
 
 
